ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,042 | +91.4% | 2,287 | +131.5% | 0.00% | – |
| Q2 2023 | $13,082 | +269.7% | 988 | +280.0% | 0.00% | – |
| Q1 2023 | $3,539 | -89.3% | 260 | -84.6% | 0.00% | – |
| Q4 2022 | $32,948 | -11.0% | 1,687 | -14.3% | 0.00% | – |
| Q3 2022 | $37,000 | +8.8% | 1,969 | +22.2% | 0.00% | – |
| Q2 2022 | $34,000 | +88.9% | 1,611 | +186.1% | 0.00% | – |
| Q1 2022 | $18,000 | – | 563 | +11160.0% | 0.00% | – |
| Q1 2021 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |